← Back
$PTHS All transactions

Pelthos Therapeutics Inc.

A

$ Value

Shares

255,000

Price

Filed

Jul 23

Insider

Name

Plesha Scott M.

Title

CEO and President

CIK

0001726687

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

255,000

Footnotes

On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 83,678 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years. | On July 2, 2025, the Reporting Person was granted stock options to purchase 255,000 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.

Filing Info

Accession No.

0001753926-25-001175

Form Type

4

Issuer CIK

0001919246

Plesha Scott M.'s History

Date Ticker Type Value
2025-07-02 PTHS A $0
2025-07-02 PTHS A
2025-07-02 PTHS A

Other Insiders at PTHS (90d)

Insider Bought Sold Last
Greenleaf Peter $17K 2026-04-02
Davis Todd C 2025-07-02
Francis Knuettel II
CFO, Treas & Secty
2025-07-02
Pauls Matthew $16K 2026-04-02
Friedberg Ezra M $12K 2026-04-02
Plesha Scott M.
CEO and President
2025-07-02
Malamut Richard $12K 2026-04-02
Baxter Richard B 2025-07-02
Rangarao Sai
Chief Commercial Officer
2025-07-02